Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - IN
$ 14.9
0.472 %
$ 12.4 B
Market Cap
19.35
P/E
RDY - COST OF REVENUE
Cost of Revenue RDY - Dr. Reddy's Laboratories Limited
116 B
LAST VALUE
7.20%
2 YEAR CAGR
10.41%
5 YEAR CAGR
7.44%
10 YEAR CAGR